Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.

<h4>Background</h4>In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circul...

Full description

Bibliographic Details
Main Authors: Wemboo Afiwa Halatoko, Yao Rodion Konu, Fifonsi Adjidossi Gbeasor-Komlanvi, Arnold Junior Sadio, Martin Kouame Tchankoni, Koffi Segbeaya Komlanvi, Mounerou Salou, Ameyo Monique Dorkenoo, Issaka Maman, Amétépé Agbobli, Majesté Ihou Wateba, Komi Séraphin Adjoh, Edem Goeh-Akue, Yem-Bla Kao, Innocent Kpeto, Paul Pana, Rebecca Kinde-Sossou, Agbeko Tamekloe, Josée Nayo-Apétsianyi, Simon-Pierre Hamadi Assane, Mireille Prine-David, Sossinou Marcel Awoussi, Mohaman Djibril, Moustafa Mijiyawa, Anoumou Claver Dagnra, Didier Koumavi Ekouevi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0242124
id doaj-c575d4a26fbf489abf178463a6b14172
record_format Article
spelling doaj-c575d4a26fbf489abf178463a6b141722021-03-04T11:52:40ZengPublic Library of Science (PLoS)PLoS ONE1932-62032020-01-011511e024212410.1371/journal.pone.0242124Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.Wemboo Afiwa HalatokoYao Rodion KonuFifonsi Adjidossi Gbeasor-KomlanviArnold Junior SadioMartin Kouame TchankoniKoffi Segbeaya KomlanviMounerou SalouAmeyo Monique DorkenooIssaka MamanAmétépé AgbobliMajesté Ihou WatebaKomi Séraphin AdjohEdem Goeh-AkueYem-Bla KaoInnocent KpetoPaul PanaRebecca Kinde-SossouAgbeko TamekloeJosée Nayo-ApétsianyiSimon-Pierre Hamadi AssaneMireille Prine-DavidSossinou Marcel AwoussiMohaman DjibrilMoustafa MijiyawaAnoumou Claver DagnraDidier Koumavi Ekouevi<h4>Background</h4>In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country.<h4>Objective</h4>This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé.<h4>Materials and methods</h4>From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.<h4>Results</h4>A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9-2.6%.<h4>Conclusion</h4>The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.https://doi.org/10.1371/journal.pone.0242124
collection DOAJ
language English
format Article
sources DOAJ
author Wemboo Afiwa Halatoko
Yao Rodion Konu
Fifonsi Adjidossi Gbeasor-Komlanvi
Arnold Junior Sadio
Martin Kouame Tchankoni
Koffi Segbeaya Komlanvi
Mounerou Salou
Ameyo Monique Dorkenoo
Issaka Maman
Amétépé Agbobli
Majesté Ihou Wateba
Komi Séraphin Adjoh
Edem Goeh-Akue
Yem-Bla Kao
Innocent Kpeto
Paul Pana
Rebecca Kinde-Sossou
Agbeko Tamekloe
Josée Nayo-Apétsianyi
Simon-Pierre Hamadi Assane
Mireille Prine-David
Sossinou Marcel Awoussi
Mohaman Djibril
Moustafa Mijiyawa
Anoumou Claver Dagnra
Didier Koumavi Ekouevi
spellingShingle Wemboo Afiwa Halatoko
Yao Rodion Konu
Fifonsi Adjidossi Gbeasor-Komlanvi
Arnold Junior Sadio
Martin Kouame Tchankoni
Koffi Segbeaya Komlanvi
Mounerou Salou
Ameyo Monique Dorkenoo
Issaka Maman
Amétépé Agbobli
Majesté Ihou Wateba
Komi Séraphin Adjoh
Edem Goeh-Akue
Yem-Bla Kao
Innocent Kpeto
Paul Pana
Rebecca Kinde-Sossou
Agbeko Tamekloe
Josée Nayo-Apétsianyi
Simon-Pierre Hamadi Assane
Mireille Prine-David
Sossinou Marcel Awoussi
Mohaman Djibril
Moustafa Mijiyawa
Anoumou Claver Dagnra
Didier Koumavi Ekouevi
Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
PLoS ONE
author_facet Wemboo Afiwa Halatoko
Yao Rodion Konu
Fifonsi Adjidossi Gbeasor-Komlanvi
Arnold Junior Sadio
Martin Kouame Tchankoni
Koffi Segbeaya Komlanvi
Mounerou Salou
Ameyo Monique Dorkenoo
Issaka Maman
Amétépé Agbobli
Majesté Ihou Wateba
Komi Séraphin Adjoh
Edem Goeh-Akue
Yem-Bla Kao
Innocent Kpeto
Paul Pana
Rebecca Kinde-Sossou
Agbeko Tamekloe
Josée Nayo-Apétsianyi
Simon-Pierre Hamadi Assane
Mireille Prine-David
Sossinou Marcel Awoussi
Mohaman Djibril
Moustafa Mijiyawa
Anoumou Claver Dagnra
Didier Koumavi Ekouevi
author_sort Wemboo Afiwa Halatoko
title Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
title_short Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
title_full Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
title_fullStr Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
title_full_unstemmed Prevalence of SARS-CoV-2 among high-risk populations in Lomé (Togo) in 2020.
title_sort prevalence of sars-cov-2 among high-risk populations in lomé (togo) in 2020.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2020-01-01
description <h4>Background</h4>In December 2019, the COVID-19 outbreak began in China and quickly spread throughout the world and was reclassified as a pandemic in March 2020. The first case of COVID-19 was declared in Togo on March 5. Two months later, few data were available to describe the circulation of the new coronavirus in the country.<h4>Objective</h4>This survey aimed to estimate the prevalence of SARS-CoV-2 in high-risk populations in Lomé.<h4>Materials and methods</h4>From April 23, 2020, to May 8, 2020, we recruited a sample of participants from five sectors: health care, air transport, police, road transport and informal. We collected oropharyngeal swabs for direct detection through real-time reverse transcription polymerase chain reaction (rRT-PCR) and blood for antibody detection by serological tests. The overall prevalence (current and past) of infection was defined by positivity for both tests.<h4>Results</h4>A total of 955 participants with a median age of 36 (IQR 32-43) were included, and 71.6% (n = 684) were men. Approximately 22.1% (n = 212) were from the air transport sector, 20.5% (n = 196) were from the police sector, and 38.7% (n = 370) were from the health sector. Seven participants (0.7%, 95% CI: 0.3-1.6%) had a positive rRT-PCR test result at the time of recruitment, and nine (0.9%, 95% CI: 0.4-1.8%) were seropositive for IgM or IgG against SARS-CoV-2. We found an overall prevalence of 1.6% (n = 15), 95% CI: 0.9-2.6%.<h4>Conclusion</h4>The prevalence of SARS-CoV-2 infection among high-risk populations in Lomé was relatively low and could be explained by the various measures taken by the Togolese government. Therefore, we recommend targeted screening.
url https://doi.org/10.1371/journal.pone.0242124
work_keys_str_mv AT wembooafiwahalatoko prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT yaorodionkonu prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT fifonsiadjidossigbeasorkomlanvi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT arnoldjuniorsadio prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT martinkouametchankoni prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT koffisegbeayakomlanvi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT mounerousalou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT ameyomoniquedorkenoo prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT issakamaman prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT ametepeagbobli prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT majesteihouwateba prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT komiseraphinadjoh prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT edemgoehakue prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT yemblakao prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT innocentkpeto prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT paulpana prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT rebeccakindesossou prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT agbekotamekloe prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT joseenayoapetsianyi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT simonpierrehamadiassane prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT mireilleprinedavid prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT sossinoumarcelawoussi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT mohamandjibril prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT moustafamijiyawa prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT anoumouclaverdagnra prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
AT didierkoumaviekouevi prevalenceofsarscov2amonghighriskpopulationsinlometogoin2020
_version_ 1714803370480369664